123 related articles for article (PubMed ID: 23106290)
1. Marked eosinophilia with abnormal basophilic granules in acute graft-versus-host disease post-allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia without CBFB-MYH11 mutation.
Chew E; Mason KD; Juneja S
Eur J Haematol; 2013 Feb; 90(2):175-6. PubMed ID: 23106290
[No Abstract] [Full Text] [Related]
2. [Inv(16)-type acute myeloid leukemia with repeated skin infiltration without bone marrow relapse before and after allogeneic hematopoietic stem cell transplantation].
Tokita K; Takahashi W; Arai H; Handa T; Nakamura Y; Maki K; Sasaki K; Mitani K
Rinsho Ketsueki; 2013 Dec; 54(12):2203-6. PubMed ID: 24452154
[TBL] [Abstract][Full Text] [Related]
3. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of post-transplant CBFB-MYH11 as minimal residual disease, rather than KIT mutations, can predict relapse after allogeneic haematopoietic cell transplantation in adults with inv(16) acute myeloid leukaemia.
Tang FF; Xu LP; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Yan CH; Sun YQ; Mo XD; Liu KY; Huang XJ
Br J Haematol; 2018 Feb; 180(3):448-451. PubMed ID: 27650511
[No Abstract] [Full Text] [Related]
5. Eosinophil chimerism in the differential diagnosis between DEK-NUP214-positive acute myeloid leukaemia relapse and chronic graft-versus-host disease.
e Moura de Souza CL; Bub CB; Torres MA; Velloso ED; Silveira PA; Correia RP; Bacal NS; Mangueira CL; Fernandes JF; Odone Filho V; Hamerschlak N; Campregher PV
J Clin Pathol; 2015 Nov; 68(11):950-2. PubMed ID: 26193901
[No Abstract] [Full Text] [Related]
6. Acute myeloid leukaemia with abnormal eosinophil precursors without inversion 16.
Rashidi A; Roullet MR
Br J Haematol; 2012 Sep; 158(5):561. PubMed ID: 22758220
[No Abstract] [Full Text] [Related]
7. Severe eosinophilia as a manifestation of acute graft-versus-host disease.
Paralkar VR; Goradia A; Luger SM; Loren AW
Oncology; 2008; 75(3-4):134-6. PubMed ID: 18791329
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
Novitzky N; Thomas V; du Toit C; McDonald A
Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and prognostic value of concomitant eosinophilia in chronic graft-versus-host disease after allogeneic stem cell transplantation.
Mortensen KB; Gerds TA; Bjerrum OW; Lindmark A; Sengeløv H; Andersen CL
Leuk Res; 2014 Mar; 38(3):334-9. PubMed ID: 24439053
[TBL] [Abstract][Full Text] [Related]
10. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
Lee JH; Lee JH; Kim DY; Yun SC; Kim SD; Choi Y; Lee YS; Kang YA; Jeon MJ; Seol M; Lee KH
Eur J Haematol; 2011 Aug; 87(2):172-81. PubMed ID: 21599753
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease: case report and review of literature.
Jing X; Halat S; Meleg-Smith S
J La State Med Soc; 2006; 158(1):20-4. PubMed ID: 16602481
[TBL] [Abstract][Full Text] [Related]
12. A mixed-type autoimmune hemolytic anemia with immune thrombocytopenia related with myositis and post-transplantation lymphoproliferative disorder.
Ogura M; Ichikawa M; Masuda A; Kandabashi K; Nannya Y; Kurokawa M
Ann Hematol; 2014 May; 93(5):869-71. PubMed ID: 24013519
[No Abstract] [Full Text] [Related]
13. Acute myeloid leukaemia with associated eosinophilia: justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion gene.
Sorour Y; Dalley CD; Snowden JA; Cross NC; Reilly JT
Br J Haematol; 2009 Jul; 146(2):225-7. PubMed ID: 19466970
[No Abstract] [Full Text] [Related]
14. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Byrne JL; Stainer C; Hyde H; Miflin G; Haynes AP; Bessell EM; Russell NH
Bone Marrow Transplant; 1998 Sep; 22(6):541-5. PubMed ID: 9758340
[TBL] [Abstract][Full Text] [Related]
15. Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
Damiani D; Tiribelli M; Geromin A; Cerno M; Sperotto A; Toffoletti E; Simeone E; Michelutti A; Cavallin M; Fanin R
Ann Hematol; 2012 Dec; 91(12):1937-43. PubMed ID: 22893485
[TBL] [Abstract][Full Text] [Related]
16. Favorable outcomes after allogeneic hematopoietic stem cell transplantation in children with high-risk or advanced acute myeloid leukemia.
Koh KN; Park M; Kim BE; Bae KW; Im HJ; Seo JJ
J Pediatr Hematol Oncol; 2011 May; 33(4):281-8. PubMed ID: 21464766
[TBL] [Abstract][Full Text] [Related]
17. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
Caira M; Girmenia C; Fadda RM; Mitra ME; Picardi M; Van Lint MT; Nosari A; Candoni A; Bonini A; Mattei D; de Waure C; Fianchi L; Valentini CG; Aversa F; Leone G; Pagano L
Eur J Haematol; 2008 Sep; 81(3):242-3. PubMed ID: 18485113
[No Abstract] [Full Text] [Related]
18. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
Rowe JM
Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
